Johan Nicolaï

534 total citations
22 papers, 392 citations indexed

About

Johan Nicolaï is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Johan Nicolaï has authored 22 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 9 papers in Pediatrics, Perinatology and Child Health and 9 papers in Pharmacology. Recurrent topics in Johan Nicolaï's work include Drug Transport and Resistance Mechanisms (13 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Johan Nicolaï is often cited by papers focused on Drug Transport and Resistance Mechanisms (13 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Johan Nicolaï collaborates with scholars based in Belgium, Netherlands and United Kingdom. Johan Nicolaï's co-authors include Pieter Annaert, Patrick Augustijns, Janneke Keemink, Tom De Bruyn, Sarinj Fattah, Sagnik Chatterjee, Saskia N. de Wildt, Anne Smits, Benoit Cox and Karel Allegaert and has published in prestigious journals such as Pharmacological Reviews, International Journal of Molecular Sciences and International Journal of Pharmaceutics.

In The Last Decade

Johan Nicolaï

21 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johan Nicolaï Belgium 12 140 130 129 74 60 22 392
Zaiqi Wang United States 9 80 0.6× 171 1.3× 271 2.1× 92 1.2× 98 1.6× 16 632
Mary Piotrowski United States 7 79 0.6× 154 1.2× 84 0.7× 70 0.9× 91 1.5× 8 355
Sarah F. Cook United States 8 62 0.4× 37 0.3× 122 0.9× 37 0.5× 37 0.6× 15 304
Hannah Britz Germany 8 67 0.5× 104 0.8× 170 1.3× 53 0.7× 54 0.9× 8 348
A Viani Italy 11 75 0.5× 116 0.9× 102 0.8× 77 1.0× 136 2.3× 25 450
Tomomi Iwakiri Japan 10 56 0.4× 100 0.8× 120 0.9× 66 0.9× 107 1.8× 24 384
Prasarn Manitpisitkul United States 15 78 0.6× 77 0.6× 77 0.6× 78 1.1× 81 1.4× 23 434
Lise Eliot Canada 10 72 0.5× 99 0.8× 95 0.7× 127 1.7× 75 1.3× 18 533
Eriko Higashi Japan 11 52 0.4× 142 1.1× 274 2.1× 38 0.5× 249 4.2× 16 595
Tanaka Japan 7 54 0.4× 55 0.4× 164 1.3× 27 0.4× 123 2.0× 13 472

Countries citing papers authored by Johan Nicolaï

Since Specialization
Citations

This map shows the geographic impact of Johan Nicolaï's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Nicolaï with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Nicolaï more than expected).

Fields of papers citing papers by Johan Nicolaï

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Nicolaï. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Nicolaï. The network helps show where Johan Nicolaï may publish in the future.

Co-authorship network of co-authors of Johan Nicolaï

This figure shows the co-authorship network connecting the top 25 collaborators of Johan Nicolaï. A scholar is included among the top collaborators of Johan Nicolaï based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan Nicolaï. Johan Nicolaï is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nicolaï, Johan, et al.. (2025). Toward improved clearance predictions and distribution profiles employing the isolated perfused rat liver model: Experimental optimization. Drug Metabolism and Disposition. 53(3). 100045–100045.
2.
Cox, Benoit, Johan Nicolaï, & Beth Williamson. (2022). The role of the efflux transporter, P‐glycoprotein, at the blood–brain barrier in drug discovery. Biopharmaceutics & Drug Disposition. 44(1). 113–126. 23 indexed citations
3.
Nicolaï, Johan, et al.. (2022). Drug clearance by aldehyde oxidase: can we avoid clinical failure?. Xenobiotica. 52(8). 890–903. 5 indexed citations
4.
Nicolaï, Johan, Karin Barnouin, Miriam G. Mooij, et al.. (2021). Ontogeny of Small Intestinal Drug Transporters and Metabolizing Enzymes Based on Targeted Quantitative Proteomics. Drug Metabolism and Disposition. 49(12). 1038–1046. 31 indexed citations
5.
Groen, Bianca D. van, Johan Nicolaï, Steven Van Cruchten, et al.. (2021). Ontogeny of Hepatic Transporters and Drug-Metabolizing Enzymes in Humans and in Nonclinical Species. Pharmacological Reviews. 73(2). 597–678. 76 indexed citations
6.
Gijsen, Matthias, Erwin Dreesen, Pieter Annaert, et al.. (2021). Meropenem Pharmacokinetics and Target Attainment in Critically Ill Patients Are Not Affected by Extracorporeal Membrane Oxygenation: A Matched Cohort Analysis. Microorganisms. 9(6). 1310–1310. 15 indexed citations
7.
Chanteux, Hugues, et al.. (2020). (–)-N-3-Benzylphenobarbital Is Superior to Omeprazole and (+)-N-3-Benzylnirvanol as a CYP2C19 Inhibitor in Suspended Human Hepatocytes. Drug Metabolism and Disposition. 48(11). 1121–1128. 3 indexed citations
8.
Smits, Anne, et al.. (2020). Population pharmacokinetics of propofol in neonates and infants: Gestational and postnatal age to determine clearance maturation. British Journal of Clinical Pharmacology. 87(4). 2089–2097. 8 indexed citations
9.
Nicolaï, Johan, Hélène Chapy, Kenneth Saunders, et al.. (2020). Impact of In Vitro Passive Permeability in a P-gp-transfected LLC-PK1 Model on the Prediction of the Rat and Human Unbound Brain-to-Plasma Concentration Ratio. Pharmaceutical Research. 37(9). 175–175. 12 indexed citations
10.
Groen, Bianca D. van, Venkatesh Pilla Reddy, Justine Badée, et al.. (2020). Pediatric Pharmacokinetics and Dose Predictions: A Report of a Satellite Meeting to the 10th Juvenile Toxicity Symposium. Clinical and Translational Science. 14(1). 29–35. 10 indexed citations
11.
Chanteux, Hugues, et al.. (2020). Application of Azamulin to Determine the Contribution of CYP3A4/5 to Drug Metabolic Clearance Using Human Hepatocytes. Drug Metabolism and Disposition. 48(9). 778–787. 7 indexed citations
12.
Johnson, Trevor N., Khaled Abduljalil, Jean‐Marie Nicolas, et al.. (2020). Use of a physiologically based pharmacokinetic–pharmacodynamic model for initial dose prediction and escalation during a paediatric clinical trial. British Journal of Clinical Pharmacology. 87(3). 1378–1389. 17 indexed citations
13.
Nicolas, Jean‐Marie, et al.. (2019). Role of P-glycoprotein in the brain disposition of seletalisib: Evaluation of the potential for drug-drug interactions. European Journal of Pharmaceutical Sciences. 142. 105122–105122. 3 indexed citations
14.
Qi, Bing, et al.. (2019). A sensitive liquid chromatography method for analysis of propofol in small volumes of neonatal blood. Journal of Clinical Pharmacy and Therapeutics. 45(1). 128–133. 5 indexed citations
15.
Gouka, Robin J., Mario A. Vermeer, Guus Duchateau, et al.. (2019). Novel natural and synthetic inhibitors of solute carriers SGLT1 and SGLT2. Pharmacology Research & Perspectives. 7(4). e00504–e00504. 13 indexed citations
16.
Nicolaï, Johan, Bing Qi, Bruno Stieger, et al.. (2017). Role of the OATP Transporter Family and a Benzbromarone-SensitiveEfflux Transporter in the Hepatocellular Disposition of Vincristine. Pharmaceutical Research. 34(11). 2336–2348. 8 indexed citations
17.
Keemink, Janneke, Benjamin Wuyts, Johan Nicolaï, et al.. (2015). In vitro disposition profiling of heterocyclic compounds. International Journal of Pharmaceutics. 491(1-2). 78–90. 3 indexed citations
18.
Nicolaï, Johan, Tom De Bruyn, Paul P. Van Veldhoven, et al.. (2015). Verapamil hepatic clearance in four preclinical rat models: towards activity‐based scaling. Biopharmaceutics & Drug Disposition. 36(7). 462–480. 14 indexed citations
19.
Bruyn, Tom De, Sagnik Chatterjee, Sarinj Fattah, et al.. (2013). Sandwich-cultured hepatocytes: utility forin vitroexploration of hepatobiliary drug disposition and drug-induced hepatotoxicity. Expert Opinion on Drug Metabolism & Toxicology. 9(5). 589–616. 99 indexed citations
20.
Vles, Georges, et al.. (2009). Levetiracetam therapy for treatment of choreoathetosis in dyskinetic cerebral palsy. Developmental Medicine & Child Neurology. 51(6). 487–490. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zaiqi Wang Breakdown of academic impact, for papers by Mary Piotrowski Breakdown of academic impact, for papers by Sarah F. Cook Breakdown of academic impact, for papers by Hannah Britz Breakdown of academic impact, for papers by A Viani Breakdown of academic impact, for papers by Tomomi Iwakiri Breakdown of academic impact, for papers by Prasarn Manitpisitkul Breakdown of academic impact, for papers by Lise Eliot Breakdown of academic impact, for papers by Eriko Higashi Breakdown of academic impact, for papers by Tanaka
Rankless by CCL
2026